196 related articles for article (PubMed ID: 22397371)
1. Structure-based analysis of VDAC1: N-terminus location, translocation, channel gating and association with anti-apoptotic proteins.
Geula S; Ben-Hail D; Shoshan-Barmatz V
Biochem J; 2012 Jun; 444(3):475-85. PubMed ID: 22397371
[TBL] [Abstract][Full Text] [Related]
2. The VDAC1 N-terminus is essential both for apoptosis and the protective effect of anti-apoptotic proteins.
Abu-Hamad S; Arbel N; Calo D; Arzoine L; Israelson A; Keinan N; Ben-Romano R; Friedman O; Shoshan-Barmatz V
J Cell Sci; 2009 Jun; 122(Pt 11):1906-16. PubMed ID: 19461077
[TBL] [Abstract][Full Text] [Related]
3. VDAC1 cysteine residues: topology and function in channel activity and apoptosis.
Aram L; Geula S; Arbel N; Shoshan-Barmatz V
Biochem J; 2010 Apr; 427(3):445-54. PubMed ID: 20192921
[TBL] [Abstract][Full Text] [Related]
4. The mitochondrial voltage-dependent anion channel 1 in tumor cells.
Shoshan-Barmatz V; Ben-Hail D; Admoni L; Krelin Y; Tripathi SS
Biochim Biophys Acta; 2015 Oct; 1848(10 Pt B):2547-75. PubMed ID: 25448878
[TBL] [Abstract][Full Text] [Related]
5. Molecular model of hexokinase binding to the outer mitochondrial membrane porin (VDAC1): Implication for the design of new cancer therapies.
Rosano C
Mitochondrion; 2011 May; 11(3):513-9. PubMed ID: 21315184
[TBL] [Abstract][Full Text] [Related]
6. Affixing N-terminal α-helix to the wall of the voltage-dependent anion channel does not prevent its voltage gating.
Teijido O; Ujwal R; Hillerdal CO; Kullman L; Rostovtseva TK; Abramson J
J Biol Chem; 2012 Mar; 287(14):11437-45. PubMed ID: 22275367
[TBL] [Abstract][Full Text] [Related]
7. Determination of the conformation of the human VDAC1 N-terminal peptide, a protein moiety essential for the functional properties of the pore.
De Pinto V; Tomasello F; Messina A; Guarino F; Benz R; La Mendola D; Magrì A; Milardi D; Pappalardo G
Chembiochem; 2007 May; 8(7):744-56. PubMed ID: 17387661
[TBL] [Abstract][Full Text] [Related]
8. Apoptosis is regulated by the VDAC1 N-terminal region and by VDAC oligomerization: release of cytochrome c, AIF and Smac/Diablo.
Shoshan-Barmatz V; Keinan N; Abu-Hamad S; Tyomkin D; Aram L
Biochim Biophys Acta; 2010; 1797(6-7):1281-91. PubMed ID: 20214874
[TBL] [Abstract][Full Text] [Related]
9. Key regions of VDAC1 functioning in apoptosis induction and regulation by hexokinase.
Shoshan-Barmatz V; Zakar M; Rosenthal K; Abu-Hamad S
Biochim Biophys Acta; 2009 May; 1787(5):421-30. PubMed ID: 19094960
[TBL] [Abstract][Full Text] [Related]
10. Swapping of the N-terminus of VDAC1 with VDAC3 restores full activity of the channel and confers anti-aging features to the cell.
Reina S; Palermo V; Guarnera A; Guarino F; Messina A; Mazzoni C; De Pinto V
FEBS Lett; 2010 Jul; 584(13):2837-44. PubMed ID: 20434446
[TBL] [Abstract][Full Text] [Related]
11. VDAC1, having a shorter N-terminus than VDAC2 but showing the same migration in an SDS-polyacrylamide gel, is the predominant form expressed in mitochondria of various tissues.
Yamamoto T; Yamada A; Watanabe M; Yoshimura Y; Yamazaki N; Yoshimura Y; Yamauchi T; Kataoka M; Nagata T; Terada H; Shinohara Y
J Proteome Res; 2006 Dec; 5(12):3336-44. PubMed ID: 17137335
[TBL] [Abstract][Full Text] [Related]
12. Mapping the ruthenium red-binding site of the voltage-dependent anion channel-1.
Israelson A; Zaid H; Abu-Hamad S; Nahon E; Shoshan-Barmatz V
Cell Calcium; 2008 Feb; 43(2):196-204. PubMed ID: 17590433
[TBL] [Abstract][Full Text] [Related]
13. Dominant-negative VDAC1 mutants reveal oligomeric VDAC1 to be the active unit in mitochondria-mediated apoptosis.
Mader A; Abu-Hamad S; Arbel N; Gutiérrez-Aguilar M; Shoshan-Barmatz V
Biochem J; 2010 Jul; 429(1):147-55. PubMed ID: 20420578
[TBL] [Abstract][Full Text] [Related]
14. Oligomerization of the mitochondrial protein VDAC1: from structure to function and cancer therapy.
Shoshan-Barmatz V; Mizrachi D; Keinan N
Prog Mol Biol Transl Sci; 2013; 117():303-34. PubMed ID: 23663973
[TBL] [Abstract][Full Text] [Related]
15. Structure-based analysis of VDAC1 protein: defining oligomer contact sites.
Geula S; Naveed H; Liang J; Shoshan-Barmatz V
J Biol Chem; 2012 Jan; 287(3):2179-90. PubMed ID: 22117062
[TBL] [Abstract][Full Text] [Related]
16. An N-terminal nucleotide-binding site in VDAC1: involvement in regulating mitochondrial function.
Yehezkel G; Abu-Hamad S; Shoshan-Barmatz V
J Cell Physiol; 2007 Aug; 212(2):551-61. PubMed ID: 17503466
[TBL] [Abstract][Full Text] [Related]
17. Mediation of the antiapoptotic activity of Bcl-xL protein upon interaction with VDAC1 protein.
Arbel N; Ben-Hail D; Shoshan-Barmatz V
J Biol Chem; 2012 Jun; 287(27):23152-61. PubMed ID: 22589539
[TBL] [Abstract][Full Text] [Related]
18. Increased expression of VDAC1 sensitizes carcinoma cells to apoptosis induced by DNA cross-linking agents.
Sharaf el dein O; Gallerne C; Brenner C; Lemaire C
Biochem Pharmacol; 2012 May; 83(9):1172-82. PubMed ID: 22285227
[TBL] [Abstract][Full Text] [Related]
19. The BH4 domain of anti-apoptotic Bcl-XL, but not that of the related Bcl-2, limits the voltage-dependent anion channel 1 (VDAC1)-mediated transfer of pro-apoptotic Ca2+ signals to mitochondria.
Monaco G; Decrock E; Arbel N; van Vliet AR; La Rovere RM; De Smedt H; Parys JB; Agostinis P; Leybaert L; Shoshan-Barmatz V; Bultynck G
J Biol Chem; 2015 Apr; 290(14):9150-61. PubMed ID: 25681439
[TBL] [Abstract][Full Text] [Related]
20. A tag at the carboxy terminus prevents membrane integration of VDAC1 in mammalian mitochondria.
Kozjak-Pavlovic V; Ross K; Götz M; Goosmann C; Rudel T
J Mol Biol; 2010 Mar; 397(1):219-32. PubMed ID: 20117113
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
